Showing 3431-3440 of 7034 results for "".
- Study Uncovers How B Cells React to Melanomahttps://practicaldermatology.com/news/study-uncovers-how-b-cells-react-to-melanoma/2461773/Antibody-producing B cells may be defective in responding to melanoma, a new study suggests. The study is published in Nature Communications. Researchers used advanced technologies to delve into the antibody immune response in blood and tissues of patients with m
- Galderma's Cetaphil® Launches Limited-edition Product Display Honoring Camp Wonderhttps://practicaldermatology.com/news/galdermas-cetaphil-launches-limited-edition-product-display-honoring-camp-wonder/2458529/Galderma Laboratories is unveiling a limited-edition product display in partnership with the Children's Skin Disease Foundation (CSDF) and Camp Wonder, an initiative of the CSDF. As part of a fi
- Modernizing Medicine's EMA Achieves ONC HIT 2014 Edition EHR Certificationhttps://practicaldermatology.com/news/20140506-modernizing_medicines_ema_achieves_onc_hit_2014_edition_ehr_certification/2459245/Modernizing Medicine's EMA has achieved ONC HIT 2014 Edition Complete EHR certification, meaning that it will be capable of supporting eligible providers and hospitals with meeting the Stage 1 and Stage 2 Meaningful Use measures of the EHR incentive program. EMA version 4.0 and EMA Mobile version 4.
- Dominion Aesthetic Technologies Closes $23.7 Million Series B Financing to Accelerate the Commercialization of EONhttps://practicaldermatology.com/news/dominion-aesthetic-technologies-closes-237-million-series-b-financing-to-accelerate-the-commercialization-of-eon/2460672/Dominion Aesthetic Technologies, developers of EON, closed Series B financing, raising a total of $23.7 million. The series B funding will accelerate the manufacturing and commercialization of EON, an FDA-cleared 1064 nm robotic laser device used for touchless, external non-invasi
- COVID-19 By the Numbers: April 28 Editionhttps://practicaldermatology.com/news/covid-19-by-the-numbers-april-28-edition/2460365/The CDC now lists nine potential symptoms of COVID-19, though cough and shortness of breath or difficulty breathing remain hallmarks of the disease. CDC says individuals may have COVID-19 if they experience these two symptoms plus at least two of the following: Fever
- COVID-19 By the Numbers: May 5 Editionhttps://practicaldermatology.com/news/covid-19-by-the-numbers-may-5-edition/2460375/Sixteen states have significantly reduced COVID-19 restrictions, while 18 have somewhat reduced restrictions, a new analysis from WalletHub reveals. The easing comes as the US reports nearly 70,000 COVI
- COVID-19 By the Numbers: April 21 Editionhttps://practicaldermatology.com/news/covid-19-by-the-numbers-april-21-edition/2460357/More than 300,000 Americans could die if all social distancing measures are abandoned, according to documents obtained by the Center for Public Inte
- COVID-19 By the Numbers: April 14 Editionhttps://practicaldermatology.com/news/covid-19-by-the-numbers-april-14-edition/2460346/The US may have already reached its peak for medical resource utilization associated with COVID-19, according to estimates from the Institute for Health Metrics and Evaluation (IHME), an independent population health resea
- COVID-19 By the Numbers: April 7 Editionhttps://practicaldermatology.com/news/covid-19-by-the-numbers-april-7-edition/2460341/The peak for medical resource utilization related to COVID-19 in the US is estimated to hit on April 15, and deaths will peak on April 16, according to the Institute for Health Metrics and Evaluation (IHME), an independent population health research center at UW Medicine at the University of
- LITE: Home-Based UV-B Phototherapy Matches Office-Based Treatment in Psoriasishttps://practicaldermatology.com/news/lite-home-based-uv-b-phototherapy-matches-office-based-treatment-psoriasis/2468330/Results from a new study suggest home-based narrowband UV-B phototherapy for psoriasis is noninferior to office-based treatment in achieving clear skin and improving patient quality of life. The researchers conducted the analysis across 42 dermatology practices in the United States and inc